Switzerland· 54594002
Riamet 80 mg/480 mg, Tabletten
A artemether and lumefantrine product, registered in Switzerland by Novartis Pharma Schweiz AG and dispensed under Swissmedic category A. The same ATC class is registered in 7 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Artemether and lumefantrine is registered in 7 of 19 countries.
Countries holding a registration under ATC P01BF01 (artemether and lumefantrine), each read from that country’s own register.
- This record: Switzerland
- 5 of them publish a price we can compare per daily dose
Artemether and lumefantrine · ATC P01BF01
7 / 19 countries
- Belgiumprice
- Finlandprice
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of artemether and lumefantrine costs, country by country.
Normalised to the WHO defined daily dose (0.28 g), so markets compare like for like.
- Switzerland: $19.10 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Artemether and lumefantrine · price per daily dose (0.28 g)
USD · FX 28 Sept 2026
- CH Switzerland$19.10
The record
At a glance
- Manufacturer
- Novartis Pharma Schweiz AG
- Country
- Switzerland (CH)
- ATC code
- P01BF01
- ATC class
- Artemether and lumefantrine
- Defined daily dose
- 0.28 g, O
- Swissmedic category
- A
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for artemether and lumefantrine.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Artemether and lumefantrine · interactions on record
1 record
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under P01BF01
Artemether and lumefantrine, as other registers publish it.
- United StatesCOARTEMNovartis Pharmaceuticals Corporation
- FinlandRiametNovartis Finland Oy
- NorwayRiametNovartis (2)
- BelgiumRiamet 20 mg - 120 mgNovartis Pharma
- NetherlandsRiamet 20 mg/120 mg, tablettenNovartis Pharma B.V.
- SwitzerlandRiamet 20 mg/120 mg, TablettenNovartis Pharma Schweiz AG
- SwitzerlandRiamet 20 mg/120 mg, TablettenNovartis Pharma Schweiz AG
- SwitzerlandRiamet Baby, Tabletten zur Herstellung einer Suspension zum EinnehmenNovartis Pharma Schweiz AG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/28192292-d63d-4808-aa9e-807e33ceb43b GET /v1/drugs/28192292-d63d-4808-aa9e-807e33ceb43b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about artemether and lumefantrine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.